
### [NCIT:C27720](http://purl.obolibrary.org/obo/NCIT_C27720)
**Label:** Pancreatic Neuroendocrine Tumor

**Subclasses:** [NCIT:C27454](http://purl.obolibrary.org/obo/NCIT_C27454) (Pancreatic VIP-Producing Neuroendocrine Tumor), [NCIT:C135564](http://purl.obolibrary.org/obo/NCIT_C135564) (Stage IV Pancreatic Neuroendocrine Tumor AJCC v8), [NCIT:C135563](http://purl.obolibrary.org/obo/NCIT_C135563) (Stage III Pancreatic Neuroendocrine Tumor AJCC v8), [NCIT:C3140](http://purl.obolibrary.org/obo/NCIT_C3140) (Pancreatic Insulin-Producing Neuroendocrine Tumor), [NCIT:C3062](http://purl.obolibrary.org/obo/NCIT_C3062) (Pancreatic Glucagon-Producing Neuroendocrine Tumor), [NCIT:C95585](http://purl.obolibrary.org/obo/NCIT_C95585) (Non-Functional Pancreatic Neuroendocrine Tumor G1), [NCIT:C45841](http://purl.obolibrary.org/obo/NCIT_C45841) (Functional Pancreatic Neuroendocrine Tumor G2), [NCIT:C45840](http://purl.obolibrary.org/obo/NCIT_C45840) (Functional Pancreatic Neuroendocrine Tumor), [NCIT:C95584](http://purl.obolibrary.org/obo/NCIT_C95584) (Pancreatic Neuroendocrine Tumor G1), [NCIT:C135562](http://purl.obolibrary.org/obo/NCIT_C135562) (Stage II Pancreatic Neuroendocrine Tumor AJCC v8), [NCIT:C135561](http://purl.obolibrary.org/obo/NCIT_C135561) (Stage I Pancreatic Neuroendocrine Tumor AJCC v8), [NCIT:C9069](http://purl.obolibrary.org/obo/NCIT_C9069) (Pancreatic Gastrin-Producing Neuroendocrine Tumor), [NCIT:C135560](http://purl.obolibrary.org/obo/NCIT_C135560) (Pancreatic Neuroendocrine Tumor by AJCC v8 Stage), [NCIT:C67369](http://purl.obolibrary.org/obo/NCIT_C67369) (Malignant Pancreatic Somatostatinoma), [NCIT:C65187](http://purl.obolibrary.org/obo/NCIT_C65187) (Malignant Pancreatic Glucagonoma), [NCIT:C28333](http://purl.obolibrary.org/obo/NCIT_C28333) (Non-Functional Pancreatic Delta Cell Neuroendocrine Tumor), [NCIT:C27466](http://purl.obolibrary.org/obo/NCIT_C27466) (Pancreatic ACTH-Producing Neuroendocrine Tumor), [NCIT:C4446](http://purl.obolibrary.org/obo/NCIT_C4446) (Enterochromaffin Cell Serotonin-Producing Pancreatic Neuroendocrine Tumor), [NCIT:C28396](http://purl.obolibrary.org/obo/NCIT_C28396) (Pancreatic Delta Cell Neuroendocrine Tumor), [NCIT:C8006](http://purl.obolibrary.org/obo/NCIT_C8006) (Pancreatic Somatostatin-Producing Neuroendocrine Tumor), [NCIT:C95597](http://purl.obolibrary.org/obo/NCIT_C95597) (Pancreatic Glucagonoma), [NCIT:C95595](http://purl.obolibrary.org/obo/NCIT_C95595) (Pancreatic Somatostatinoma), [NCIT:C45835](http://purl.obolibrary.org/obo/NCIT_C45835) (Pancreatic Neuroendocrine Tumor G2), [NCIT:C45838](http://purl.obolibrary.org/obo/NCIT_C45838) (Non-Functional Pancreatic Neuroendocrine Tumor G2), [NCIT:C45837](http://purl.obolibrary.org/obo/NCIT_C45837) (Non-Functional Pancreatic Neuroendocrine Tumor), 

**Class expressions from DL-Learner:**

- Thing 54.66%
- [NCIT:C45861](http://purl.obolibrary.org/obo/NCIT_C45861) (del(18q21)) 52.38%
- [NCIT:C45859](http://purl.obolibrary.org/obo/NCIT_C45859) (Loss of Chromosome 3q) 52.38%
- [NCIT:C45858](http://purl.obolibrary.org/obo/NCIT_C45858) (Gain of Chromosome 4) 52.38%
- [NCIT:C39909](http://purl.obolibrary.org/obo/NCIT_C39909) (Gain of Chromosome 18q) 52.38%
- [NCIT:C37312](http://purl.obolibrary.org/obo/NCIT_C37312) (Loss of Chromosome 11q) 52.38%
- [NCIT:C36592](http://purl.obolibrary.org/obo/NCIT_C36592) (Gain of Chromosome 9q34) 52.38%
- [NCIT:C36585](http://purl.obolibrary.org/obo/NCIT_C36585) (Loss of Chromosome 10) 52.38%
- [NCIT:C36583](http://purl.obolibrary.org/obo/NCIT_C36583) (Loss of Chromosome 6q) 52.38%
- [NCIT:C36569](http://purl.obolibrary.org/obo/NCIT_C36569) (del(1p36)) 52.38%
- [NCIT:C36545](http://purl.obolibrary.org/obo/NCIT_C36545) (Gain of Chromosome 5q) 52.38%
- [NCIT:C36504](http://purl.obolibrary.org/obo/NCIT_C36504) (Loss of Chromosome 6) 52.38%
- [NCIT:C36502](http://purl.obolibrary.org/obo/NCIT_C36502) (Loss of Chromosome 3p) 52.38%
- [NCIT:C36481](http://purl.obolibrary.org/obo/NCIT_C36481) (Gain of Chromosome 15q) 52.38%
- [NCIT:C36480](http://purl.obolibrary.org/obo/NCIT_C36480) (Gain of Chromosome 20q) 52.38%


